PSSR yields 800.00% · JNJ yields 2.13%● Live data
📍 PSSR pulled ahead of the other in Year 1
Combined, PSSR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSSR + JNJ for your $10,000?
PASSUR Aerospace, Inc., a business intelligence company, provides predictive analytics and decision support technology for the aviation industry in the United States and internationally. The company's products, include ARiVAT EMPO, a dynamic gate-to-gate global flight tracking; ARiVA AWARE that provides continuous forecasts and alerts to achieve the most efficient execution of the daily operation; and ARiVA WORKFLOW, an integrated communication and collaboration on shared workflow platform to maximize use of existing assets and capacity. Its products also comprise ARiVA INTEL Data, a reporting and analytical tool that enable insights into operational performance to drive continuous improvement; ARIVA BIZAV, a complete set of tools to help forecast and manage the operation; ARIVA LFM, which ensures various landing fees and related charges are being fully and accurately captured and billed; and ARiVA STRATEGY that integrates commercial strategies and operational priorities. It serves airlines and airports. PASSUR Aerospace, Inc. was founded in 1967 and is headquartered in Stamford, Connecticut.
Full PSSR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.